EKR Therapeutics Overview

  • Founded
  • 2006
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $150M
Latest Deal Amount

EKR Therapeutics General Information


Developer of prescription products intended to serve the needs of the acute-care hospital setting. The company's products support the life of cancer patients, offer short-term treatment of hypertension and management of various AMI related conditions, enabling patients to get access to preferred treatment at a cost effective manner.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Therapeutic Devices
Primary Office
  • Third Floor
  • Bedminster Township
  • NJ 07921
  • United States
+1 (877) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

EKR Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 27-Jun-2012 $150M 00000 00000 Completed Generating Revenue
4. Later Stage VC (Series D) 10-Mar-2008 00000 00000 Completed Startup
3. Later Stage VC (Series C) 22-Aug-2007 000.00 000.00 Completed Startup
2. Early Stage VC (Series B) 15-Nov-2006 $7.33M $7.33M Completed Startup
1. Early Stage VC (Series A) 27-Jun-2006 Completed Startup
To view EKR Therapeutics’s complete valuation and funding history, request access »

EKR Therapeutics Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Commerce Health Ventures Venture Capital Minority 000 0000 000000 0
ESP Equity Partners PE/Buyout Minority 000 0000 000000 0
Garden State Life Sciences Venture Fund Venture Capital Minority 000 0000 000000 0
LLR Partners PE/Buyout Minority 000 0000 000000 0
MPM Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »